EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Chemistry in Disability Care: Biomarkers, Risk-based Monitoring, and Inclusive Laboratory Services in Saudi Arabia

Abubaker M. Hamad, Naif Jameel Alshehri, Mohamed Hashim Albashir, Bayan Ahmad Dous, Altayeb Hasan Elkhalifa

Journal of Disability Research · 2026 · 5 (4)

DOI: 10.57197/jdr-2026-1105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Disability Research, 2026. Verfasst von Abubaker M. Hamad und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical chemistry supports the prevention, diagnosis, prognosis, longitudinal monitoring, treatment safety, and detection of secondary health risks. Because many common chronic and treatment-related conditions are assessed through biochemical testing, equitable disability care requires both clinically appropriate testing and laboratory pathways adapted to patients’ physical, sensory, intellectual, developmental, neurological, and multiple disabilities. The objective of this study was to synthesize clinically actionable roles of clinical chemistry in disability care and develop a practical roadmap for Saudi Arabia. This structured narrative review was informed by searches of PubMed, Scopus, and Web of Science from database inception to September 2026. Search concepts combined disability terms with clinical chemistry/biomarker, metabolic/endocrine, nutritional/mineral, renal/hepatic, medication monitoring, specimen collection, accessibility, point-of-care, home sampling, and communication terms. Evidence was retained when a laboratory test, biomarker, monitoring strategy, or service adaptation had a substantive and clinically interpretable role in disability care. Artificial intelligence-assisted tools were used only to prioritize screening; final eligibility and evidence verification were performed by human reviewers. Findings were synthesized narratively by clinical function and the total testing pathway. Four recurring functions emerged: early detection and prognostic assessment; risk-based monitoring in people with disabilities; prevention or detection of secondary complications; and adaptation of laboratory services to improve access and specimen collection for people with disabilities. Representative clinical areas included glucose and lipid monitoring, renal and hepatic function, medication-related laboratory monitoring, nutritional and metabolic abnormalities, and selected biomarkers relevant to neurological or developmental conditions. The evidence supports distinguishing biomarkers of an underlying condition from biomarkers of associated risk, treatment safety, and secondary complications. Trace-element studies involving zinc, copper, selenium, and related elements were identified, but evidence for routine disability-specific clinical use remains limited. Evidence for analytically validated alternative sampling, accessible communication of laboratory results, and closed-loop follow-up also remains comparatively sparse. In summary, clinical chemistry in disability care extends beyond biomarker discovery to longitudinal surveillance and accessible service delivery. For Saudi Arabia, priorities include risk-based monitoring, reasonable adjustments for specimen collection, selective use of decentralized or alternative sampling, accessible communication, and implementation research across the total testing pathway.

Zitieren

APA

Hamad, A. M., Alshehri, N. J., Albashir, M. H., Dous, B. A., & Elkhalifa, A. H. (2026). Clinical Chemistry in Disability Care: Biomarkers, Risk-based Monitoring, and Inclusive Laboratory Services in Saudi Arabia. Journal of Disability Research, 5(4). https://doi.org/10.57197/jdr-2026-1105

Vancouver

Hamad AM, Alshehri NJ, Albashir MH, Dous BA, Elkhalifa AH. Clinical Chemistry in Disability Care: Biomarkers, Risk-based Monitoring, and Inclusive Laboratory Services in Saudi Arabia. Journal of Disability Research. 2026;5(4). doi:10.57197/jdr-2026-1105

BibTeX
@article{Hamad2026,
  author = {Hamad, Abubaker M. and Alshehri, Naif Jameel and Albashir, Mohamed Hashim and Dous, Bayan Ahmad and Elkhalifa, Altayeb Hasan},
  title = {Clinical Chemistry in Disability Care: Biomarkers, Risk-based Monitoring, and Inclusive Laboratory Services in Saudi Arabia},
  journal = {Journal of Disability Research},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.57197/jdr-2026-1105}
}
Kostenlos starten →